TP53 Signature Can Predict Pathological Response From Neoadjuvant Chemotherapy and Is a Prognostic Factor in Patients With Residual Disease

por Takahashi, Shin, Sasaki, Keiju, Ishioka, Chikashi
Publicado 2023

Different impacts of TP53 mutations on cell cycle-related gene expression among cancer types

por Sasaki, Keiju, Takahashi, Shin, Ouchi, Kota, Otsuki, Yasufumi, Wakayama, Shonosuke, Ishioka, Chikashi
Publicado 2023

Altered gene expression due to aberrant DNA methylation correlates with responsiveness to anti‐EGFR antibody treatment

por Otsuki, Yasufumi, Ouchi, Kota, Takahashi, Shin, Sasaki, Keiju, Sakamoto, Yasuhiro, Okita, Akira, Ishioka, Chikashi
Publicado 2022

Depth of response may predict clinical outcome in patients with recurrent/metastatic head and neck cancer treated with pembrolizumab-containing regimens

por Saijo, Ken, Imai, Hiroo, Ouchi, Kota, Sasaki, Keiju, Yoshida, Yuya, Kawamura, Yoshifumi, Taniguchi, Sakura, Kasahara, Yuki, Komine, Keigo, Shirota, Hidekazu, Takahashi, Masanobu, Ishioka, Chikashi
Publicado 2023

Antibiotics Improve the Treatment Efficacy of Oxaliplatin-Based but Not Irinotecan-Based Therapy in Advanced Colorectal Cancer Patients

por Imai, Hiroo, Saijo, Ken, Komine, Keigo, Yoshida, Yuya, Sasaki, Keiju, Suzuki, Asako, Ouchi, Kota, Takahashi, Masahiro, Takahashi, Shin, Shirota, Hidekazu, Takahashi, Masanobu, Ishioka, Chikashi
Publicado 2020